Freeline Reports Updated Data From Phase 1/2 B-AMAZE Trial in Hemophilia B

Freeline Reports Updated Data From Phase 1/2 B-AMAZE Trial in Hemophilia B

Globe Newswire

Image

Please enable the javascript to submit this form

Supported by educational grants from Bayer, BioMarin, CSL Behring, Freeline Therapeutics Limited, Pfizer Inc., Spark Therapeutics, and uniQure, Inc.

Essential SSL